Significant improvement in overall survival among patients diagnosed with low‐risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

    loading  Loading Related Articles